Valuation: Monogram Technologies Inc.

Market Cap 244M 214M 202M 184M 345M 23.37B 347M 2.42B 936M 11.94B 915M 896M 38.37B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 200M 189M 173M 323M 21.9B 325M 2.27B 878M 11.19B 858M 839M 35.95B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 5.8
Extreme 5.8001
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap. Importance
10/7/25 Issuer sale

Chief Financial Officer

411,385 1.0125%
10/7/25 Issuer sale

Chief Executive Officer

5,566,330 13.6993%
10/7/25 Issuer sale

Director

40,000 0.0984%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+1.87%+105.48% 244M
+0.97%-1.00%-26.10%-5.23% 104B
+0.35%-1.90%-23.58%-3.12% 11.23B
-0.29%-5.73%+89.55%+102.21% 9.1B
-1.29%+3.12%-49.04%-67.22% 4.14B
-0.91%+6.44%-25.51%+26.97% 2.49B
+2.46%-8.18%-8.82%-61.91% 2.04B
-3.28%+0.48% - - 1.94B
-1.43%+0.29%-24.06%-32.26% 1.53B
Average -0.58%-0.72%-8.21%+8.11% 15.24B
Weighted average by Cap. +0.66%-1.20%-18.47%-0.09%

Financials

2023 2024
Net sales 0.36 0.32 0.3 0.28 0.52 34.98 0.52 3.62 1.4 17.87 1.37 1.34 57.44 -
Net income -13.75M -12.06M -11.39M -10.38M -19.43M -1.32B -19.57M -136M -52.8M -673M -51.61M -50.49M -2.16B -16.33M -14.33M -13.53M -12.33M -23.08M -1.56B -23.25M -162M -62.72M -800M -61.31M -59.98M -2.57B
Net Debt -13.1M -11.49M -10.85M -9.89M -18.52M -1.26B -18.65M -130M -50.31M -641M -49.17M -48.11M -2.06B -15.33M -13.45M -12.7M -11.58M -21.67M -1.47B -21.82M -152M -58.87M -750M -57.54M -56.3M -2.41B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
-
  1. Stock Market
  2. Stocks
  3. MGRM Stock